Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.7K

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability

Sinda Zarrouk1, Josef Finsterer2

  • 1University of Tunis El Manar and Genomics Platform, Pasteur Institute of Tunis, Tunis, Tunisia.

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
|October 4, 2021
PubMed

Insights

Sinus venous thrombosis (SVT) is a recognized complication of COVID-19 and its vaccines, linked to hypercoagulability. Early recognition and accurate treatment are crucial for preventing unfavorable outcomes in these patients.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Sinus venous thrombosis (SVT) is an increasingly recognized complication associated with SARS-CoV-2 infection and vaccination.
  • Hypercoagulability, a common complication of COVID-19 regardless of severity, contributes to SVT development.
  • Mechanisms include platelet activation, endothelial cell dysfunction, complement pathway activation, and immune thrombocytopenia.

Purpose of the Study:

  • To highlight the association between SARS-CoV-2 and SVT.
  • To explain the underlying mechanisms of hypercoagulability in COVID-19 leading to SVT.
  • To emphasize the need for accurate prevention and treatment strategies for SVT in the context of COVID-19.

Main Methods:

  • Review of current literature on SVT, SARS-CoV-2 infection, and COVID-19 vaccination.
  • Analysis of proposed pathophysiological mechanisms linking SARS-CoV-2 to hypercoagulability and thrombosis.
  • Discussion of clinical implications and management considerations.

Main Results:

  • SVT is a significant risk in both COVID-19 infection and vaccination.
  • Multiple pathways contribute to COVID-19-induced hypercoagulability, increasing thrombotic risk.
  • SVT can occur even in anticoagulated patients, underscoring treatment challenges.

Conclusions:

  • SVT represents a serious complication of SARS-CoV-2 infection and vaccination.
  • Understanding the hypercoagulable state is key to managing SVT.
  • Proactive prevention and precise treatment are essential to improve patient outcomes.

Keywords:
COVID-19ComplicationsHypercoagulabilitySARS-CoV-2Thrombosis

More Related Videos

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

25.0K
Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method08:07

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method

Published on: July 4, 2021

3.7K

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
79
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
68
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Overview of Systemic Veins01:11

Overview of Systemic Veins

Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
782
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
51
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K